Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes

To identify the core gut microbial features associated with type 2 diabetes risk and potential demographic, adiposity, and dietary factors associated with these features. We used an interpretable machine learning framework to identify the type 2 diabetes-related gut microbiome features in the cross-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2021-02, Vol.44 (2), p.358-366
Hauptverfasser: Gou, Wanglong, Ling, Chu-Wen, He, Yan, Jiang, Zengliang, Fu, Yuanqing, Xu, Fengzhe, Miao, Zelei, Sun, Ting-Yu, Lin, Jie-Sheng, Zhu, Hui-Lian, Zhou, Hongwei, Chen, Yu-Ming, Zheng, Ju-Sheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To identify the core gut microbial features associated with type 2 diabetes risk and potential demographic, adiposity, and dietary factors associated with these features. We used an interpretable machine learning framework to identify the type 2 diabetes-related gut microbiome features in the cross-sectional analyses of three Chinese cohorts: one discovery cohort ( = 1,832, 270 cases of type 2 diabetes) and two validation cohorts (cohort 1: = 203, 48 cases; cohort 2: = 7,009, 608 cases). We constructed a microbiome risk score (MRS) with the identified features. We examined the prospective association of the MRS with glucose increment in 249 participants without type 2 diabetes and assessed the correlation between the MRS and host blood metabolites ( = 1,016). We transferred human fecal samples with different MRS levels to germ-free mice to confirm the MRS-type 2 diabetes relationship. We then examined the prospective association of demographic, adiposity, and dietary factors with the MRS ( = 1,832). The MRS (including 14 microbial features) consistently associated with type 2 diabetes, with risk ratio for per 1-unit change in MRS 1.28 (95% CI 1.23-1.33), 1.23 (1.13-1.34), and 1.12 (1.06-1.18) across three cohorts. The MRS was positively associated with future glucose increment ( < 0.05) and was correlated with a variety of gut microbiota-derived blood metabolites. Animal study further confirmed the MRS-type 2 diabetes relationship. Body fat distribution was found to be a key factor modulating the gut microbiome-type 2 diabetes relationship. Our results reveal a core set of gut microbiome features associated with type 2 diabetes risk and future glucose increment.
ISSN:0149-5992
1935-5548
DOI:10.2337/dc20-1536